The Synermed® cholesterol methodology enhances signal to noise ratio as compared to traditional automated methods in two ways. First, the chromophore produced has more than twice the molar absorbance compared to the most commonly used automated methods. Second, the shift in wavelength to the infrared diminishes absorbance due to lipemia, bilirubin and hemoglobin. The overall signal to noise enhancement is about 700% for lipemia. Hemoglobin and bilirubin produce no chromatic interference in the method.
The improved performance relative to chromatic substances is dramatic in the application of the method to HDL cholesterol.
Most applications of this procedure have been found to be linear to 24 mmol/L (929 mg/dL).
The recommendations of the Adult Treatement Panel of the National Cholesterol Education Program for Classificaiton of Patients is as follows:
Risk Classification Total Cholesterol in Blood | |
Desirable | <5,17 mmol/L (<200 mg/dL) |
Borderline High | 5.17-6.18 mmol/L (200-239 mg/dL) |
High | >6.20 mmol/L (>240 mg/dL) |
Mean | SD | CV |
4.0 mmol/L (155 mg/dL) | 0.038 (1.5) | 0.96% |
5.7 mmol/L (221 mg/dL) | 0.043 (1.7) | 0.76% |
Mean | SD | CV |
3.02 mmol/L (117 mg/dL) | 0.04 (1.5) | 1.2% |
7.63 mmol/L (295 mg/dL) | 0.11 (4.3) | 1.4% |
Cat No. | Product Name | Packaging | Package Volume (mL) | Storage |
IR060-X | Cholesterol | 1x250 mL + 1x100 mL | 350 | 0-4° C |
IR060 | Cholesterol | 3x250 mL + 3x100 mL | 1,050 | 0-4° C |
IR061-L | Cholesterol Chromogen | 6x1000 mL | 6,000 | 0-4° C |
IR062-L | Cholesterol Enzyme | 6x500 mL | 3,000 | 0-4° C |
IR060-911 | Cholesterol | 6x50 mL + 3x40 mL | 420 | 0-4° C |
IR060-WK | Cholesterol | 3x25mL + 3x10mL | 105 | 0-4° C |